Unexpectedly, although long-term (6 months) supplementation of inulin (7.5%) improves metabolic syndrome in toll-like receptor 5 (TLR5)-knockout mice, many of these mice develop icteric hepatocellular carcinoma (HCC) [19]. This evidence concerns the gene TLR5 and metabolic syndrome.